Pincus Capital Management, LP has filed its Form 13F-HR report for the period ending September 30, 2026. The filing discloses the firm's equity holdings as of the close of that quarter.
The report lists a total of 51 distinct equity securities held by the firm. The largest position disclosed in the filing is Merck & Co. Inc., for which the firm holds 42,496 shares. Other significant positions include Procter & Gamble Co., with 237,023 shares, and Microsoft Corporation, with 17,751 shares.
The portfolio is heavily weighted toward technology and healthcare sectors. Major holdings include NVIDIA Corporation (10,954 shares), Apple Inc. (67,617 shares), and Eli Lilly & Co. (2,431 shares). The filing also lists substantial positions in Visa Inc. (12,138 shares) and Taiwan Semiconductor Manufacturing Sponsored ADS (1,816 shares).
In addition to individual stocks, the portfolio includes various exchange-traded funds (ETFs). Significant ETF holdings include the Invesco QQQ Trust (15,896 shares) and the SPDR S&P 500 ETF Trust (6,536 shares).
